(Reuters) - Rubber products maker Ansell Ltd (>> Ansell Limited) announced writedowns and restructuring on Thursday following the sale of its flagship condoms business two months ago.

Ansell said it will spend US$70 million to $100 million (76.76 million pounds) over three years to reorganise its supply chain, merge its single-use and medical divisions into a "healthcare" unit and find other cost savings.

It also announced non-cash asset write downs of $20 million to $30 million related to the closure of some "smaller, less efficient" production lines.

Ansell in May sold its oldest division, which produced condoms, for $600 million to China's Humanwell Healthcare Group Co Ltd (>> Humanwell Healthcare Group Co Ltd) and CITIC Capital China Partners LP.

($1 = 1.2566 Australian dollars)

(Reporting by Susan Mathew in Bengaluru. Editing by Tom Westbrook and)

Stocks treated in this article : Ansell Limited, Humanwell Healthcare Group Co Ltd